Cargando…
The p38α mitogen-activated protein kinase as a central nervous system drug discovery target
Protein kinases are critical modulators of a variety of cellular signal transduction pathways, and abnormal phosphorylation events can be a cause or contributor to disease progression in a variety of disorders. This has led to the emergence of protein kinases as an important new class of drug target...
Autores principales: | Borders, Aaron S, de Almeida, Lucia, Van Eldik, Linda J, Watterson, D Martin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2604896/ https://www.ncbi.nlm.nih.gov/pubmed/19090985 http://dx.doi.org/10.1186/1471-2202-9-S2-S12 |
Ejemplares similares
-
Redox-dependent dimerization of p38α mitogen-activated protein kinase with mitogen-activated protein kinase kinase 3
por: Bassi, Rekha, et al.
Publicado: (2017) -
Targeting Human Central Nervous System Protein Kinases:
An Isoform Selective p38αMAPK Inhibitor That Attenuates Disease
Progression in Alzheimer’s Disease Mouse Models
por: Roy, Saktimayee M., et al.
Publicado: (2015) -
Functions of p38 MAP Kinases in the Central Nervous System
por: Asih, Prita R., et al.
Publicado: (2020) -
p38α Mitogen-Activated Protein Kinase Is a Druggable Target in Pancreatic Adenocarcinoma
por: Yang, Ling, et al.
Publicado: (2019) -
P38 Mitogen-activated Protein Kinase and Parkinson’s Disease
por: He, Jianying, et al.
Publicado: (2018)